Health benefits of apple phenolics from postharvest stages for potential type 2 diabetes management using in vitro models

Journal of Food Biochemistry

Volumn 34, Issue 1, 2010, Pages 31-49

  Adyanthaya, I ^a   Kwon, Y I ^a   Apostolidis, E ^a   Shetty, K ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MALUS X DOMESTICA;

EID: 77449100979     PISSN: 01458884     EISSN: 17454514     Source Type: Journal    
DOI: 10.1111/j.1745-4514.2009.00257.x     Document Type: Article

References (32)

1. Adyanthaya I, Kwon Y-I, Apostolidis E, Shetty K. Apple post-harvest preservation linked to phenolics and SOD activity. J. Food Biochem. 2009, 33:535-556.
2. Bischoff H. Pharmacology of glucosidase inhibitor. Eur. J. Clin. Invest. 1994, 24:3-10.
3. Bischoff H, Puls W, Krause HP, Schutt H, Thomas G. Pharmacological properties of the novel glucosidase inhibitors BAY m 1099 (miglitol) and BAY o 1248. Diabetes Res. Clin. Pract. 1985, 1:53-62.
4. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 1992, 18:1-29.
5. Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutr. J. 2004, 3:5.
6. Brownlee M. The pathobiology of diabetic complications. Diabetes 2005, 54:1615-1625.
7. Fonseca V. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus. Curr. Med. Res. Opin. 2003, 19:635-641.
8. Harris MI, Zimmer P. Classification of diabetes mellitus and other categories of glucose intolerance. International Textbook of Diabetes Mellitus 1992, 3-18. Alberti KGGM, Defronzo RAKeen HZimmer P. In, eds.) pp., John Wiley, London, U.K
9. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J. Clin. Invest. 1995, 96:1802-1814.
10. Hertog M, Feskens E. Dietary antioxidant flavonoids and risk of coronary heart disease. Lancet 1993, 342:1007-1011.
11. Hertog MGL, Kromhout D, Aravanis C, Blacburn H, Buzina R, Fridanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven counties study. Arch. Intern. Med. 1995, 155:381-386.
12. Horii S, Fukasse K, Matsuo T, Kameda K, Asano N, Masui Y. Synthesis and α-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potent oral antidiabetic agents. J. Med. Chem. 1987, 29:1038-1046.
13. Kaiser N, Sasson S, Feener EP, Boukobza N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, King GL. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1993, 42:80-89.
14. Knekt P, Jarvinen R, Seppanen R, Heliovaara M, Teppo L, Pukkala E, Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 1997, 146:223-230.
15. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakilinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76:560-568.
16. Kwon Y-I, Vattem DA, Shetty K. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac. J. Clin. Nutr. 2006, 15:107-118.
17. Kwon Y-I, Apostolidis E, Shetty K. Evaluation of pepper (Capsicum annuum) for management of diabetes and hypertension. J. Food Biochem. 2007, 31:370-385.
18. Mccue P, Kwon Y-I, Shetty K. Anti-amylase, anti-glucosidase and anti-angiotension I converting enzyme potential of select foods. J. Food Biochem. 2005, 29:278-294.
19. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000, 404:787-790.
20. Puls W, Keup U. Metabolic studies with an amylase. Recent Advances in Obesity Research 1975, 391. Howard A, In, Vol. 1, ed.) p., Newman Publisher, London, U.K
21. Puls W, Keup U, Krause H, Thomas PG, Hoffmeister F. Glucosidase inhibition: a new approach to the treatment of diabetes, obesity and hyperlipoproteinemia. Naturwissen Schaften. 1977, 64:536-537.
22. Ratner RE. Controlling postprandial hyperglycemia. Am. J. Cardiol. 2001, 88:26-31.
23. Serdula MK, Byers MAH, Simoes E, Mendlein JM, Coates RJ. The association between fruit and vegetable intake and chronic disease risk factors. Epidemiology 1996, 7:161-165.
24. Shetty K. Biotechnology to harness the benefits of dietary phenolics; focus on lamiaceae. Asia Pac. J. Clin. Nutr. 1997, 6:162-171.
25. Shetty K. Phytochemicals: Biotechnology of phenolic phytochemicals for food preservatives and functional food applications. Wiley Encyclopedia of Food Science and Technology 1999, -1909. Francis FJ. In, 2nd, Ed., ed.) pp., Wiley Publishers, New York
26. Shetty K. Biosynthesis of rosmarinic acid and applications in medicine. J. Herbs. Species Med. Plants 2001, 8:161-181.
27. Shetty K, Labbe RL. Food-borne pathogens, health and role dietary phytochemicals. Asia Pac. J. Clin. Nutr. 1998, 7:270-276.
28. Shetty K, Wahlqvist ML. A model for the role of the proline-linked pentose-phosphate pathway in phenolic phytochemical biosynthesis and mechanism of action for human health and environmental applications. Asia Pac. J. Clin. Nutr. 2004, 13:1-24.
29. Shetty K, Curtis OF, Levin RE, Witkowsky R, Ang W. Prevention of vitrification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. J. Plant Physiol. 1995, 147:447-451.
30. Sun J, Chu Y, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J. Agric. Food Chem. 2002, 50:7449-7454.
31. Tsao R, Yang R, Xie S, Sockoyie E, Khanizadeh S. Which polyphenolic compounds contribute to the total antioxidant activities of apple? J. Agr. Food. Chem. 2005, 53:4989-4995.
32. Vinson JA. Phenol antioxidant quantity and quality in foods: fruits. J. Agric. Food Chem 2001, 49:5315-5321.